TY - JOUR
T1 - The Role of Mobile Health Technologies in Allergy Care
T2 - an EAACI Position Paper
AU - Matricardi, Paolo Maria
AU - Dramburg, Stephanie
AU - Alvarez-Perea, Alberto
AU - Antolín-Amérigo, Darío
AU - Apfelbacher, Christian
AU - Atanaskovic-Markovic, Marina
AU - Berger, Uwe
AU - Blaiss, Michael S
AU - Blank, Simon
AU - Boni, Elisa
AU - Bonini, Matteo
AU - Bousquet, Jean
AU - Brockow, Knut
AU - Buters, Jeroen
AU - Cardona, Victoria
AU - Caubet, Jean-Christoph
AU - Cavkaytar, Özlem
AU - Elliott, Tania
AU - Esteban-Gorgojo, Ignacio
AU - Fonseca, Joao A
AU - Gardner, James
AU - Gevaert, Philippe
AU - Ghiordanescu, Ileana
AU - Hellings, Peter
AU - Hoffmann-Sommergruber, Karin
AU - Kalpaklioglu, A Fusun
AU - Marmouz, Farid
AU - Meijide Calderón, Ángela
AU - Mösges, Ralph
AU - Nakonechna, Alla
AU - Ollert, Markus
AU - Oteros, José
AU - Pajno, Giovanni
AU - Panaitescu, Catalina
AU - Perez-Formigo, Daniel
AU - Pfaar, Oliver
AU - Pitsios, Constantinos
AU - Rudenko, Michael
AU - Ryan, Dermot
AU - Sánchez-García, Silvia
AU - Shih, Jennifer
AU - Tripodi, Salvatore
AU - Van der Poel, Lauri-Ann
AU - van Os-Medendorp, Harmieke
AU - Varricchi, Gilda
AU - Wittmann, Jörn
AU - Worm, Margitta
AU - Agache, Ioana
N1 - This article is protected by copyright. All rights reserved.
PY - 2019/9/16
Y1 - 2019/9/16
N2 - Mobile Health (mHealth) uses mobile communication devices such as smartphones and tablet computers to support and improve health-related services, data flow and information, patient self-management, surveillance, and disease management from the moment of first diagnosis to an optimized treatment. The European Academy of Allergy and Clinical Immunology created a task force to assess the state of the art and future potential of mHealth in allergology. The task force endorsed the "Be He@lthy, Be Mobile" WHO initiative and debated the quality, usability, efficiency, advantages, limitations, and risks of mobile solutions for allergic diseases. The results are summarized in this position paper, analyzing also the regulatory background with regard to the "General Data Protection Regulation" and Medical Directives of the European Community. The task force assessed the design, user engagement, content, potential of inducing behavioral change, credibility/accountability, and privacy policies of mHealth products. The perspectives of health care professionals and allergic patients are discussed, underlining the need of thorough investigation for an effective design of mHealth technologies as auxiliary tools to improve quality of care. Within the context of precision medicine, these could facilitate the change in perspective from clinician- to patient-centered care. The current and future potential of mHealth is then examined for specific areas of allergology, including allergic rhinitis, aerobiology, allergen immunotherapy, asthma, dermatological diseases, food allergies, anaphylaxis, insect venom, and drug allergy. The impact of mobile technologies and associated big data sets are outlined. Facts, recommendations, and an action plan for future mHealth initiatives within EAACI are listed. This article is protected by copyright. All rights reserved.
AB - Mobile Health (mHealth) uses mobile communication devices such as smartphones and tablet computers to support and improve health-related services, data flow and information, patient self-management, surveillance, and disease management from the moment of first diagnosis to an optimized treatment. The European Academy of Allergy and Clinical Immunology created a task force to assess the state of the art and future potential of mHealth in allergology. The task force endorsed the "Be He@lthy, Be Mobile" WHO initiative and debated the quality, usability, efficiency, advantages, limitations, and risks of mobile solutions for allergic diseases. The results are summarized in this position paper, analyzing also the regulatory background with regard to the "General Data Protection Regulation" and Medical Directives of the European Community. The task force assessed the design, user engagement, content, potential of inducing behavioral change, credibility/accountability, and privacy policies of mHealth products. The perspectives of health care professionals and allergic patients are discussed, underlining the need of thorough investigation for an effective design of mHealth technologies as auxiliary tools to improve quality of care. Within the context of precision medicine, these could facilitate the change in perspective from clinician- to patient-centered care. The current and future potential of mHealth is then examined for specific areas of allergology, including allergic rhinitis, aerobiology, allergen immunotherapy, asthma, dermatological diseases, food allergies, anaphylaxis, insect venom, and drug allergy. The impact of mobile technologies and associated big data sets are outlined. Facts, recommendations, and an action plan for future mHealth initiatives within EAACI are listed. This article is protected by copyright. All rights reserved.
U2 - 10.1111/all.13953
DO - 10.1111/all.13953
M3 - Article
C2 - 31230373
SN - 0105-4538
JO - Allergy
JF - Allergy
ER -